Skip to content

Clinical Research of Femtosecond Laser-Assisted Cataract Surgery

Clinical Research of Femtosecond Laser-Assisted Cataract Surgery: Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02492659
Acronym
FLACS
Enrollment
54
Registered
2015-07-09
Start date
2013-10-31
Completion date
2014-06-30
Last updated
2015-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataracts

Keywords

femtosecond laser

Brief summary

Since femtosecond laser was approved for cataract surgery by FDA in 2010, femtosecond laser assisted cataract surgery (FLACS) has demonstrated high precision of capsulotomy, reduced phacoemulsification power and time, and comparable refractive outcome in clinic. It is still unknown whether there are toxic substances produced due to photochemical or high-energy physical effect of femtosecond laser during FLACS.

Detailed description

Phacoemulsification is one of the main surgical procedures for cataract surgery owing to the advantages of small incisions and rapid recovery. However, the surgical outcome of phacoemulsification can be negatively affected due to the problem of accuracy and repeatability for capsulorhexis, and the corneal endothelial cell damage by ultrasound energy.To overcome those problems from the phacoemulsification, femtosecond laser-assisted cataract surgery (FLACS) had been used in the past few years and showed unique advantages. The purpose of this study is to investigate the preliminary clinical outcomes of femtosecond laser-assisted cataract surgery.This prospective comparative study enrolled consecutive patients,will be randomly assigned to trial group underwent FLACS and control group underwent conventional cataract surgery. The phacoemulsification time, energy, and complications during operation were recorded. The anterior capsule and aqueous humor were collected. Morphology of the cutting edge and cells of anterior capsule was assessed by light microscopy. The proteins in the aqueous humor were identified by mass spectrometry . Electrolyte in the aqueous humor was detected by a chemistry analyzer. Postoperative refraction at 1 day, 1 week, 1 and 3 months, the capsulorhexis size and corneal endothelial density at 1 and 3 months were also measured.

Interventions

the femtosecond laser platform was used to generate capsulotomy with a diameter as described above in the control group, and lens fragmentation into 6 segments.

continuous curvilinear capsulorhexis was performed with capsulorrhexis forceps. Following hydrodissection, phacoemulsification of the nucleus, aspiration of the residual cortex and capsular polishing were performed using a phacoemulsification machine

Sponsors

Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
38 Years to 86 Years
Healthy volunteers
Yes

Inclusion criteria

1. normal cornea 2. dilated pupillary diameter greater than 6mm 3. no local or systemic contraindications to cataract surgery

Exclusion criteria

1. corneal pathological changes 2. glaucoma 3. ocular inflammation 4. previous ocular trauma or surgery

Design outcomes

Primary

MeasureTime frame
the proteins in the aqueous humor after femtosecond laser operationday 1

Secondary

MeasureTime frame
the electrolyte in the aqueous humor after femtosecond laser operationday 1
morphology of the anterior capsule after femtosecond laser operationday 1

Other

MeasureTime frame
the capsulorhexis sizeafter one month,after three month
phacoemulsification energyin operation
corneal endothelial densityafter one month,after three month
phacoemulsification timein operation
postoperative refractionday 1,after one week

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026